These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36686769)

  • 1. KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status.
    Liu Q; Liu YY; Chen XM; Tao BY; Chen K; Li WM; Xu CT; Shi Y; Li H; Liu HR
    Front Oncol; 2022; 12():1071722. PubMed ID: 36686769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment.
    Jiang Z; Xing C; Wang P; Liu X; Zhong L
    Front Cell Dev Biol; 2021; 9():748269. PubMed ID: 34938730
    [No Abstract]   [Full Text] [Related]  

  • 3. The Prognostic Significance of
    Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma.
    Qi W; Bai Y; Wang Y; Liu L; Zhang Y; Yu Y; Chen H
    APMIS; 2022 Jul; 130(7):371-382. PubMed ID: 35255180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding ribonucleic acid-mediated
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Front Genet; 2022; 13():916847. PubMed ID: 36212130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma.
    Li D; Yu T; Han J; Xu X; Wu J; Song W; Liu G; Zhu H; Zeng Z
    Front Mol Biosci; 2021; 8():799651. PubMed ID: 35111813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
    Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
    Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma.
    Yoo W; Kim AK; Kook HU; Noh K
    Front Pharmacol; 2024; 15():1338929. PubMed ID: 38425648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma.
    Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT
    BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma.
    Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X
    J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma.
    Liao Y; Weng J; Chen L; Hu N; Yuan X; Wang J; He F; Cai Y; Huang Q; Wang J; Huang L
    Front Genet; 2022; 13():911378. PubMed ID: 36186480
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker.
    Deng X; Wang Y; Guo H; Wang Q; Rao S; Wu H
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC.
    Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z
    Front Oncol; 2022; 12():875097. PubMed ID: 35586489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.